HomeProductsBioactive CompoundsEpigeneticsHIFCAS 1227158-85-1
Chemical structure of CAS 1227158-85-1

1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine

CAS No.1227158-85-1
MDL No.N/A
MFC26H26F3N7O2
MW525.50
InChI KeyCDJNNOJINJAXPV-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1227158-85-1
Product Name1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine
Heavy Atom Count38Rotatable Bond Count7
Atom Stereo Count0Bond Stereo Count0
HBA9HBD0
TPSA85.340 ŲCharge0
Exact Mass525.21001Complexity1404.97
pKa9.613XLogP4.535

Related Articles

Studies related to this compound and its mechanism of action

Study on molecular mechanism of benzo (ɑ) pyrene on CMA by HSP90ɑ and HIF-1ɑ.

Toxicology in vitro : an international journal published in association with BIBRA • Vol. 83 • 2022
PMID: 35487446DOI: 10.1016/j.tiv.2022.105372

Lysosome Fe release is responsible for etoposide- and cisplatin-induced stemness of small cell lung cancer cells.

Environmental toxicology • Vol. 36, Issue 8 • 2021
PMID: 33969609DOI: 10.1002/tox.23161

BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I.

Cancer medicine • Vol. 2, Issue 5 • 2013
PMID: 24403227PMC: PMC3892793DOI: 10.1002/cam4.112

[Periarteritis nodosa and cancer. Apropos of 2 cases].

La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris • Vol. 51, Issue 40 • 1975
PMID: 2979

Documentation